Medistim ASA (OSL:MEDI)
Norway · Delayed Price · Currency is NOK 234.00
+6.00 (2.63%)
Jul 15, 2026, 4:25 PM CET
Medistim ASA Ratios and Metrics
Market cap in millions NOK. Fiscal year is January - December.
Millions NOK. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 15, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 4,281 | 4,749 | 2,741 | 3,924 | 4,236 | 6,699 | |
Market Cap Growth | 13.23% | 73.24% | -30.14% | -7.36% | -36.77% | 46.13% |
Enterprise Value | 4,105 | 4,587 | 2,597 | 3,788 | 4,100 | 6,594 |
Last Close Price | 234.00 | 259.00 | 149.50 | 214.00 | 231.00 | 367.50 |
PE Ratio | 27.41 | 29.74 | 26.37 | 37.74 | 37.02 | 73.80 |
Forward PE | 25.17 | 29.10 | 25.34 | 33.80 | 39.94 | 61.56 |
PS Ratio | 5.95 | 6.79 | 4.87 | 7.46 | 8.61 | 15.68 |
PB Ratio | 8.45 | 10.14 | 6.28 | 9.86 | 11.52 | 21.89 |
P/TBV Ratio | 10.56 | 12.38 | 7.28 | 11.11 | 12.73 | 24.31 |
P/FCF Ratio | 25.18 | 27.68 | 20.01 | 38.17 | 40.64 | 55.84 |
P/OCF Ratio | 24.39 | 25.39 | 19.16 | 32.92 | 37.32 | 52.59 |
EV/Sales Ratio | 5.70 | 6.55 | 4.62 | 7.20 | 8.34 | 15.43 |
EV/EBITDA Ratio | 19.56 | 21.61 | 17.73 | 24.42 | 24.92 | 47.20 |
EV/EBIT Ratio | 21.15 | 23.38 | 19.81 | 28.82 | 29.03 | 56.71 |
EV/FCF Ratio | 24.15 | 26.73 | 18.95 | 36.85 | 39.34 | 54.96 |
Debt / Equity Ratio | 0.07 | 0.08 | 0.06 | 0.02 | 0.03 | 0.06 |
Debt / EBITDA Ratio | 0.18 | 0.23 | 0.24 | 0.11 | 0.10 | 0.17 |
Debt / FCF Ratio | 0.19 | 0.29 | 0.25 | 0.17 | 0.16 | 0.20 |
Net Debt / Equity Ratio | -0.35 | -0.35 | -0.33 | -0.34 | -0.37 | -0.34 |
Net Debt / EBITDA Ratio | -0.91 | -0.77 | -0.99 | -0.88 | -0.82 | -0.75 |
Net Debt / FCF Ratio | -0.97 | -0.95 | -1.06 | -1.32 | -1.30 | -0.88 |
Asset Turnover | 1.07 | 1.13 | 1.04 | 1.07 | 1.11 | 1.14 |
Inventory Turnover | 0.86 | 0.80 | 0.74 | 0.86 | 1.01 | 0.92 |
Quick Ratio | 2.56 | 2.21 | 2.50 | 2.61 | 2.72 | 2.69 |
Current Ratio | 3.80 | 3.34 | 4.00 | 4.15 | 3.87 | 3.95 |
Return on Equity (ROE) | 32.01% | 35.18% | 24.88% | 27.12% | 33.83% | 23.68% |
Return on Assets (ROA) | 22.38% | 24.44% | 18.76% | 20.42% | 24.88% | 24.74% |
Return on Invested Capital (ROIC) | 47.16% | 50.56% | 36.63% | 40.87% | 50.92% | 29.44% |
Return on Capital Employed (ROCE) | 36.30% | 39.84% | 29.82% | 33.10% | 39.87% | 38.00% |
Earnings Yield | 3.65% | 3.36% | 3.79% | 2.65% | 2.70% | 1.36% |
FCF Yield | 3.97% | 3.61% | 5.00% | 2.62% | 2.46% | 1.79% |
Dividend Yield | 3.51% | 2.31% | 3.01% | 2.10% | 1.62% | 0.82% |
Payout Ratio | 70.13% | 68.76% | 79.37% | 79.15% | 60.01% | 60.11% |
Buyback Yield / Dilution | 0.14% | 0.21% | -0.10% | -0.11% | -0.15% | -0.07% |
Total Shareholder Return | 3.65% | 2.52% | 2.91% | 2.00% | 1.47% | 0.75% |